CNS & Neurological Disorders-Drug Targets

Papers
(The H4-Index of CNS & Neurological Disorders-Drug Targets is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Meet the Editorial Board Member75
Meet the Regional Editor68
Na+/HCO3− Co-transporters Inhibitor S0859 Attenuates Global Cerebral Ischemia-reperfusion Injury of the CA1 Neurons in the Gerbil’s Hippocampus51
Hypomyelination with Atrophy of Basal Ganglia and Cerebellum (HABC) Due to UFM1 Mutation in Roma Patients - Severe Early Encephalopathy with Stridor and Severe Hearing and Visual Impairment. A Single 44
Decoding the Inter-Relationship between Sleep Disorders and Alzheimer’s Disease Pathogenesis44
Neurobiology of Amphetamine use in Stroke Recovery Combined with Rehabilitative Training and Brain Stimulation43
Recent Trends in Physical Therapy Interventions and Neuromodulation Techniques to Improve Neurorehabilitation36
The Potential Effect of Blueberry on Cognitive Health and Mood State based on Human Intervention Studies: Systematic Review and Mini Meta-Analysis34
Effects of α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator on BDNF, NKCC1 and KCC2 Expression in the Hippocampus following Lipopolysaccharide-Induced Allodynia and Hyperalgesia in a 32
CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment28
Memory Reflections of the Microbiota-Gut and Oligodendrocyte Axis28
Restless Leg Syndrome in Patients with Liver Cirrhosis! Its Frequency, Severity, and Correlation25
Emerging Nanotechnology for the Treatment of Alzheimer’s Disease23
The Natural Neuroprotective Compounds Used in the 6-Hydroxydopamine- Induced Parkinson’s Disease in Zebrafish: The Current Applications and Perspectives23
Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review22
Monoamine Oxidase: A Potential Link in Papez Circuit to Generalized Anxiety Disorders22
Intracerebral Hemorrhage and Diabetes Mellitus: Blood-Brain Barrier Disruption, Pathophysiology and Cognitive Impairments22
Unraveling the Triad: A Bioinformatics Analysis of the Interplay between Prenatal Depression, Inflammation, and the Gut Microbiota21
GFAP and UCHL1 in Non-traumatic SAH: The Story thus Far. A Systematic Review of the Literature21
Cholinesterase Inhibitory and In Silico Toxicity Assessment of Thirty-Four Isoquinoline Alkaloids - Berberine as the Lead Compound21
Insights into the Diagnosis, Treatment, and Management of Prion Diseases21
The Emerging Role of Marine Natural Products for the Treatment of Parkinson’s Disease21
0.056966066360474